Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Poly-L-lactic acid for facial lipoatrophy in HIV
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Poly-L-lactic acid for facial lipoatrophy in HIV'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Facial Lipoatrophy
100%
Poly(L-lactic acid)
100%
Clinical Trials
28%
Lipoatrophy
28%
Intradermal Injection
28%
MEDLINE
14%
Clinical Data
14%
AIDS/HIV
14%
Pharmacology
14%
Adverse Effects
14%
HIV-associated
14%
Pharmacokinetics
14%
Data Extraction
14%
Biocompatibility
14%
Morphological Characteristics
14%
Literature Search
14%
People Living with HIV (PLHIV)
14%
Treatment Alternatives
14%
Injection Site
14%
Non-white
14%
Fat Loss
14%
Lipodystrophy
14%
Nodule Formation
14%
Facial Fat
14%
Hematoma Formation
14%
Sculptra
14%
Polylactic Acid
14%
Synthetic Polymers
14%
HIV-associated Lipodystrophy Syndrome
14%
Biodegradable Synthetic Polymers
14%
Polylactide
14%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Lactic Acid
100%
Lipoatrophy
100%
Clinical Trial
28%
Polylactic Acid
28%
Adverse Event
14%
Hematoma
14%
Lipodystrophy
14%
Polylactide
14%
Pharmacokinetics
14%